Aurobindo Pharma arm receives EIR from USFDA for Andhra Unit; stock down 2%

Aurobindo Pharma shares fell following the news that the US Food and Drug Administration has issued the Establishment Inspection Report (EIR) for the new injectable facility of Eugia Steriles